Skip to content

Effects of Cognitive Intervention on Cognition, Mobility and Brain Electrocortical Activity

Holistic Approach for Active and Healthy Aging: Physical and Cognitive Activity, and Nutrition

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03860441
Acronym
GIBKOP
Enrollment
77
Registered
2019-03-04
Start date
2017-07-01
Completion date
2018-09-30
Last updated
2019-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Cognitive Decline, Cognitive Impairment, Motor Coordination or Function

Keywords

cognition, mobility, cognitive reserve, EEG/ERP

Brief summary

Within this project the investigators tested the effectiveness of 2-month of computerized cognitive training (CCT) on CogniFit online platform on 77 older adults, which were randomly divided into intervention and control group. The investigators tested close (battery of cognitive functions) and far transfer (postural and mobility control, EEG, blood samples) of the CCT. Additionally, the investigators were interested into seeing a long-lasting effect, therefore participants were brought back to the laboratory 1 year post CCT.

Interventions

OTHERComputerized cognitive training

Intervention used CogniFit platform with Personalized brain training sub-option

Sponsors

University of Primorska
CollaboratorOTHER
Albert Einstein College of Medicine
CollaboratorOTHER
Vrije Universiteit Brussel
CollaboratorOTHER
Science and Research Centre Koper
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

A single-blind randomized controlled trial

Intervention model description

Participants in the intervention group followed a computerized cognitive training program for 2-months, 3x/week, 40min/session

Eligibility

Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* active and healthy older adults with no major health issues * members of the Center for Daily Activity Koper (Slovenia) * had normal or corrected-to-normal vision; * reported no history of cardiovascular, neurological, or psychiatric conditions

Exclusion criteria

* younger than 60 * smoking; regular alcohol consumption; * acute or chronic skeletal, neuromuscular, metabolic and cardiovascular disease condition;

Design outcomes

Primary

MeasureTime frameDescription
Change in gait speedup to 8 weeksThe primary outcome is change in gait speed during single- and dual-task conditions from baseline to post-intervention.

Secondary

MeasureTime frameDescription
Executive control (Trail-Making Task Forms A and B)up to 8 weeksSecondary outcome is change in executive control, measured with TMT A and B tests
Sensorimotor integration measured with EEG/ERP methodologyup to 8 weeksSecondary outcome is change ERP components P1, N1, P2 and P3 (amplitudes and latencies)
Brain-derived neurotrophic factor (BDNF) extracted from peripheral blood samplingup to 8 weeksSecondary outcome is change in plasma BDNF plasma extraction evaluated in pg/mL

Countries

Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026